Navigation Links


ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices

10/31/2014
MOUNTAIN VIEW, Calif. , Oct. 31, 2014 ThynkWare ( www.thynkware.com ) is seeking to help amyotrophic lateral sclerosis (ALS) patients initiate text and email messages using their thoughts. ThynkWare Speech is based upon a patent-pending technology invented by ThynkWare's founder, Duane Cash , which is for a mind-controlled virtual assistant on a smartphone device. This tech... [Comments]

Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate

10/31/2014
PLEASANTON, California , November 3, 2014 British Journal of Urology International paper underlines need for men with BPH to discuss "male orgasmic dysfunction" with their doctor prior to any treatment; UroLift® system shows ability to treat prostate symptoms while preserving sexual function     NeoTract, Inc., today welcomes the publication of a paper in... [Comments]

Encision Reports Second Quarter Fiscal Year 2015 Results

10/31/2014
BOULDER, Colo., Oct. 31, 2014  Encision Inc. (OTCQB:ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2015 second quarter ended September 30, 2014. The Company posted quarterly net revenue of $2.279 million for a quarterly net... [Comments]

B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L.

10/31/2014
MELBOURNE, Australia and BARCELONA , October 31, 2014 Multigate Medical Devices Pty Ltd (Multigate) was found to infringe two Australian patents of B. Braun Melsungen AG (B. Braun) by selling or offering for sale in Australia safety IV catheters manufactured by Poly Medicure Ltd (Polymed). The judgment of 17.10.14 in Federal Court of Australia proceeding number V... [Comments]

Results for the fourth quarter and the fiscal year ended June 30, 2014 - Ergoresearch reports solid 2014 annual results

10/31/2014
LAVAL, QC , Oct. 31, 2014 /CNW Telbec/ - Ergoresearch Ltd ("Ergoresearch" or "the Company") is poised, with its strategic plan, for accelerated growth in terms of sales and profitability. Annual growth in 2014 was 32.6% and revenues reached $17,862,341. Net income amounted to $1,230,153. The EBITDA reached $3,087,816, crossing the $3 million threshold for the first time in the Company's his... [Comments]

Game Changing Migraine Medication To Be Available November 2014

10/31/2014
LOS ANGELES , Oct. 30, 2014 Migranade, Inc. announced today the new migraine medication, MIGRANADE Migraine Relief will be available to the 36 million U.S. migraine sufferers November, 2014. The medicine is developed from a platform technology that targets the actual cause of migraines and not just the symptoms. While all migraine medications attack pain and not the source Mig... [Comments]

Process Validation in the US and EU (Workshop, London)

10/31/2014
DUBLIN , October 30, 2014 Research and Markets ( http://www.researchandmarkets.com/research/spmsvz/process ) has announced the addition of the  "Process Validation in the US and EU (Workshop, London)"  conference to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Key topics to include:  Science... [Comments]

E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

10/31/2014
LONDON , Oct. 30, 2014 Electronic prescribing or E-Prescribing system (eRx) is the electronic transmission of prescription related information between prescriber, dispenser and pharmacy benefit manager. E-Prescribing system allows a physician and nurse practitioner to transmit a new prescription electronically when a medication error occurs during pharmacy operations. E-Prescr... [Comments]

Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call

10/31/2014
CARLSBAD, Calif. , Oct. 31, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announces the following webcast:  What: Isis Pharmaceuticals' Third Quarter 2014 Financial Results and Highlights Conference CallWhen: Friday, November 7 at 11:30 a.m. ET / 8:30 a.m. PTWhere: www.isispharm.com How: Live on the Internet. Simply log onto our website lis... [Comments]

Report: Stem Cell Technologies Market Growing

10/31/2014
NEW YORK , Oct. 31, 2014 Though therapies are in their nascent phase, sales of stem cell technologies are expected to show an annual increase of 16.2% over the 2010-2020 period, reaching an expected market value of nearly $1 billion, according to Kalorama Information's report, Stem Cell Therapeutics Markets . This includes revenues from proprietary stem cell therapeutics... [Comments]

[next]
(Date:10/30/2014)... new treatments for injuries and damage to the joints, ... example, is a hard material that caps the ends ... Davis biomedical engineers, exploring ways to toughen up engineered ... report new developments this week in the journal ... "The problem with engineered tissue is that the mechanical ...
(Date:10/30/2014)... the DFG Research Center for Regenerative Therapies Dresden - ... for the first time the in vitro growth of ... mouse embryonic stem cells. Correct spatial organization of motor ... was observed., This study has been published online by ... on 30.10.2014 ., For many years Elly Tanaka and ...
(Date:10/30/2014)... 30, 2014 Timothy, InstaKNOT’s ... Beach firefighters, showing that you are never too young ... met firefighters Tracey and Carl at the 2013 Santa ... the Pompano Beach Chamber of Commerce. Tracey gave Timothy ... letting Timothy wear his real fireman’s hat, and extending ...
(Date:10/30/2014)... San Diego, Calif. (PRWEB) October 30, 2014 ... no longer mutually exclusive concepts in the medical-grade ... focusing on the development of uniquely potent topical ... Skin Health System ( http://www.RefinitySkinScience.com ) with patented ... highest available glycolic acid concentrations (50% and 70%) ...
(Date:10/30/2014)... N.C. (PRWEB) October 30, 2014 Paramount ... health care, is increasing efforts to help people save ... expenses continue to increase for prescription drugs in the ... valuable savings and resources to bridge the relationship between ... One of the biggest challenges people face today with ...
Breaking Medicine News(10 mins):Health News:Making lab-grown tissues stronger 2Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 2Health News:Paramount Rx Discount Card Program Provides Valuable Resources in Midst of Current Health Care Reform 3
... Children under the age of three who had hernia surgery ... later compared to children who had not undergone the surgery, ... School of Public Health and the College of Physicians and ... into the New York State Medicaid system between 1999 and ...
... Nov. 7 Schering-Plough,Corporation (NYSE: SGP ) ... portfolio managers being held on Monday, Nov. 24, ... Ph.D., executive vice,president and president, Schering-Plough Research Institute, ... The primary purpose of the,meeting is to provide ...
... (NYSE: PER ) ( http://www.perotsystems.com ) today ... 2007, will fully transition its,name to Perot Systems, ... will now refer to the group as the ... the global information,technology provider,s deep healthcare solutions expertise ...
... Ohio, Nov. 7 National Adoption Day is ... help adoption agencies, civic and,faith-based groups, corporations, educators ... Adoption Awareness Toolkit can be ordered at, http://www.davethomasfoundationforadoption.org ... to promote foster care,adoption awareness, including A Child ...
... is, few people know the first thing about clinical ... that announces unbelievable results for a miraculous drug. Some ... favorable findings. For example, a 1994 headline in the ... heart disease" but by 2001 that optimistic report was ...
... AMSTERDAM, November 7 , - Archbishop Desmond Tutu, ... On the 29th of November, fifty thousand young people ... live via satellite,young people in 19 countries will dance ... people want to inspire companies,politicians, artists and media to ...
Cached Medicine News:Health News:General anesthesia for hernia surgery in children and risk of later developmental problems 2Health News:Perot Systems Announces Name Change of JJWild 2Health News:Perot Systems Announces Name Change of JJWild 3Health News:Dave Thomas Foundation for Adoption Offers Free Foster Care Adoption Awareness Toolkits 2Health News:It's great! Oops, no it isn't 2Health News:50,000 Young People Dance to Celebrate Achievements in Pushing Back HIV and AIDS 2
For accurately monitoring core temperature and heart and breath sounds....
For accurately monitoring core temperature and heart and breath sounds....
... The bodys warmth beneath drapes. The life-giving ... are yours to guard, measure, stabilize and ... products helps you do your job, giving ... most comfortable and precise management of your ...
... Level 1 enables hospitals ... patient monitors to a ... Our temperature monitoring disposale ... are superior in their ...
Medicine Products:
(Date:10/30/2014)... 30, 2014 /CNW/ - Atlantic Canadians will save an ... Canada,s provinces and territories and ... of the Canadian Generic Pharmaceutical Association (CGPA), said today. ... speaking at the Atlantic Summit on Healthcare and Drug ... is being hosted by the Public Policy Forum and ...
(Date:10/30/2014)... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a ... the pharmaceutical, biotechnology, and medical device industries, with operations ... the United States , today announced the establishment ... Aviv area of Israel.  ... integrated R&D services to local customers. It will also ...
(Date:10/30/2014)... ANGELES , Oct. 30, 2014   ... company devoted to bringing new products to market, ... drug called TetraStem. TetraStem is a topical liquid ... delivery system that can convert oral medication active ... registered as a first aid antibiotic to help ...
Breaking Medicine Technology:Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 3WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
... SAN FRANCISCO and RIDGEFIELD, Conn., Nov. 7, 2011 ... planned interim analysis of a Phase 2b study, SOUND-C2, ... hepatitis C virus (HCV) compounds – the protease inhibitor ... ribavirin (RBV) – was successful in reducing viral load ...
... PTC Therapeutics, Inc. announced today that ... an initiative created by the Bill & Melinda ... unorthodox ideas that address persistent health and development ... pursue an innovative global health research project, titled ...
Cached Medicine Technology:Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 2Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 3Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 4Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheim's Two Investigational HCV Direct Acting Antivirals Presented at AASLD 5PTC Therapeutics Receives Grand Challenges Explorations Funding 2PTC Therapeutics Receives Grand Challenges Explorations Funding 3